TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · no major macro event
XNCR

Xencor Inc

Healthcare · Biotechnology

25.00$ +1.3% vs. previous close Closing price · As of: Sep 21, 2026

Statements

Cash Flow

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Cash Flow XNCR
Line item 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
+254.8% -135.6% -107.8% +247.6% -337.6%
+26.2% +31.7% +38.5% +60.1% +32.2% +34.8% +29.3% +17.5% +30.7% +5.3% -13.2%
+161.6% +61.2% +73.9% +50.5% +55.0% -0.7% +16.9% +32.3% +9.9% -0.9% -18.9%
+117.5% +60.4% +71.0% +48.4% +53.0% -83.3% +632.1% -43.8%
+60.7% -106.3% +785.3% -313.0% +239.8% -124.3%
+60.8% -18.1% +141.9% +25.7% +20.7% +24.7% +16.1% +171.6% -51.0% -71.3% -48.3%
+8,008.0% +15.4% -615.7% -69.1% -146.2% +158.9%
+97.2% -12.5% +585.0% -74.9% +48.8% +2.4% +28.7% +13.9% -5.5% +0.0% -34.7%
+37,686.0% +3.9% -96.9% +6,710.6% -95.8% +69.2% +138.5% -86.8% +359.2% +653.0% -95.8%
+3.2% +385.9% +147.6% +370.5% -117.7% -5,761.4%
+298.5% -144.7% -135.2% -426.2%

Data as of: September 21, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?